InvestSMART

InhaleRx Limited (ASX:IRX)

ALERT: Price-sensitive ASX Announcement for IRX
Current share price for IRX : $0.028 -0.008 (-22.22%)+
Announcement
Release
26 Nov 2025 10:42AM
Price at Release
$0.036
Full Release
download
Summary
InhaleRx Limited has announced a non-renounceable pro-rata entitlement offer to raise up to $247,668.34. The offer is set at a price of $0.025 per New Share, along with one free attaching New Option for every two New Shares subscribed. The New Options have an exercise price of $0.042 and a two-year expiry. This initiative aims to raise funds for general working capital and the costs associated with conducting the offer. Eligible shareholders have the opportunity to increase their investment and avoid potential dilution resulting from the issuance of shares under a Placement offer, which seeks to raise an additional $750,000. The offer is not underwritten, and no minimum subscription is required. Risks associated with the investment include those related to the new shares, company operations, and general market factors. The offer opens on 5 December 2025 and is scheduled to close on 17 December 2025.
Key Points
  • Non-renounceable pro-rata entitlement offer to raise $247,668.34.
  • Offer price set at $0.025 per New Share with free attaching New Options.
  • New Options have an exercise price of $0.042, expiring in two years.
  • Purpose is to fund general working capital and offer costs.
  • Entitlement offer aims to prevent dilution from Placement offer.
  • Total capital raising goal is $1,000,000 including the Placement.
  • Offer is not underwritten and requires no minimum subscription.
  • Risks include those related to new shares, company, and market.
  • Offer opens on 5 December 2025, closing on 17 December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.